Sundar Jagannath, Hans C. Lee, Joshua Ryan Richter, Jeffrey A. Zonder, James E. Hoffman, Zheng-Yi Zhou, Viviana Garcia Horton, Mirko Fillbrunn, Hongjue Wang, Matthew Mattera, Timothy J. Inocencio, Yingxin Xu, James Harnett, Tito Roccia, Glenn Scott Kroog, Karen Rodriguez-Lorenc, Kate Knorr, Qiufei Ma, Naresh Bumma. "Indirect comparison of linvoseltamab versus elranatamab for triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7531